Phonophoresis therapy for TMD pain control

Abstract

Temporomandibular dysfunction (TMD) according to Okeson, (1998) is the term used to describe a comprehensive condition of clinical changes in the orofacial region, temporomandibular joint (TMJ) and adjacent structures, where it is most commonly observed the painful symptomatology present in the dysfunctions of the masticatory muscles and cervical muscles. A non-invasive therapeutic option for TMD control is phonophoresis, a technique that associates therapeutic ultrasound with a drug, described by Skauen and Zentner (1984), as drug movement through intact living skin and soft tissues under the influence of an ultrasonic disturbance, enabling greater spreading, penetration and absorption of the drugs used.

DOI: https://doi.org/10.56238/homeinternationalanais-109